Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Successful canakinumab treatment for activated innate response in idiopathic Castleman's disease with multiple heterozygous MEFV exon 2 variants

28 Jul 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Histiocytic Disorders and Treatments
Share to Inflammasome and immune disorders
Share to Viral-associated cancers and disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32735870
DOI: 10.1016/j.clim.2020.108547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Successful canakinumab treatment for activated innate response in idiopathic Castleman's disease with multiple heterozygous MEFV exon 2 variantsPMID 32735870Read ↗

Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined genetic causeSemantic proximity Read ↗

Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's diseaseSemantic proximity Read ↗

Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ–positive juvenile dermatomyositisSemantic proximity Read ↗

PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapySemantic proximity Read ↗

NEMO splice variant causes distinct autoinflammatory syndrome.Semantic proximity Read ↗

A heterozygous variant in MEFV in a familial autoinflammatory syndrome with PAPA-like featuresSemantic proximity Read ↗

Successful hematopoietic cell transplantation in patients with unique NF-κB essential modulator (NEMO) mutations.Semantic proximity Read ↗

Silencing of immune activation with methotrexate in patients with COVID-19Semantic proximity Read ↗

Canakinumab in recessive dystrophic epidermolysis bullosa: a novel unexpected weapon for non-healing wounds?Semantic proximity Read ↗

Successful treatment with anakinra in generalized spiculated porokeratosis and severe hidradenitis suppurativa in a patient with MVK and MEFV mutations.Semantic proximity Read ↗

Treatment options for chronic mucocutaneous candidiasis.Semantic proximity Read ↗

Digenic MEFV/TNFRSF1A autoinflammatory syndrome with relapsing aseptic neutrophilic meningitis and chronic myelitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.